Nuo Therapeutics, Inc.

The current price of AURX is 0.8000 USD — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nuo Therapeutics, Inc. stocks are traded under the ticker AURX.

AURX stock is 0% volatile and has beta coefficient of −0.65. Check out the list of the most volatile stocks — is Nuo Therapeutics, Inc. there?

Yes, you can track Nuo Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

AURX stock has fallen by 15.78% compared to the previous week, the month change is a 11.11% fall, over the last year Nuo Therapeutics, Inc. has showed a 68.00% decrease.

AURX net income for the last quarter is ‪−653.16 K‬ USD, while the quarter before that showed ‪−790.64 K‬ USD of net income which accounts for 17.39% change. Track more Nuo Therapeutics, Inc. financial stats to get the full picture.

No, AURX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, AURX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuo Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

AURX reached its all-time high on Oct 5, 2022 with the price of 4.5000 USD, and its all-time low was 0.0001 USD and was reached on Dec 27, 2021.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has 9.00 employees. See our rating of the largest employees — is Nuo Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuo Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuo Therapeutics, Inc. stock shows the sell signal. See more of Nuo Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nuo Therapeutics, Inc. EBITDA is ‪−3.06 M‬ USD, and current EBITDA margin is −503.35%. See more stats in Nuo Therapeutics, Inc. financial statements.